Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors
Alessandra Castiglioni(Xalud Therapeutics (United States)), Sören Müller(Genesys (United States)), James Ziai, Marco De Simone(University of Salerno), Shannon J. Turley(California Institute for Regenerative Medicine), Justin A. Shyer, Justin Elstrott, Amber W. Wang, Wenxian Fu, Aude-Hélène Capietto(Inserm), Patricia Himmels(Molecular Oncology (United States)), Jillian L. Astarita(Harvard University), Alvin Gogineni(Angiogenesis Foundation), Katherine Williams, Jeffrey Hung, Alan Gutierrez, Tony Pourmohamad, Zora Modrušan(Unknown), Rafael Cubas(Theravance Biopharma (United States)), James T. Koerber(Genesys (United States)), Ryan S. Lane(Oregon Health & Science University), Stephen E. Gould, Ira Mellman(Unknown), Stephanie Mittman(Translational Research in Oncology), Yulei Wang, Zhe Zhang, Yeqing Angela Yang, Minh Thai, Shomyseh Sanjabi(University of California, San Francisco), Yagai Yang, Wendy Sandoval(Abterra Biosciences (United States))
Cited by 96
Related Papers
Endocytosis and the recycling of plasma membrane.
|The Journal of Cell Biology|1983|1.5k
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
|Clinical Cancer Research|2009|1.4k
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
|Cancer Cell|2014|1.1k
Cross-tissue organization of the fibroblast lineage
|Nature|2021|1.1k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945